Reinhard Krickl is the founder of Phagenesis. Phagenesis has raised $70M in total funding. Latest round: Series D.
Reinhard Krickl is the CEO of Phagenesis, a UK-based medical device company focused on neurostimulation systems for treating swallowing disorders. He has successfully led the company through significant funding rounds, transitioning it from a clinical-stage to a commercial entity.
Full founder directory · Investor directory · Company funding database · Fundraising library